Goldman Sachs Penny Stocks: Top 12 Stock Picks

Page 3 of 11

9. Clover Health Investments, Corp. (NASDAQ:CLOV)

Goldman Sachs Equity Stake: $2.65 Million

Share Price: $2.05

Number of Hedge Fund Holders: 12

Clover Health Investments, Corp. (NASDAQ:CLOV) is one of Goldman Sachs’ top penny stock picks. On January 29, 2026, Clover Health Investments, Corp. (NASDAQ:CLOV) announced it will release fourth‑quarter financial results after market close on Thursday, February 26, 2026.

The stock has been edging higher after the company disclosed on January 14 that enrollees in its Medicare Advantage Plans are already up by 53% for the 2026 plan year.

The company entered 2026 with about 153k members as of January 1, with more than 97% of its MA membership enrolled on the flagship app PPO plan. The growth remains concentrated in core markets, where the company maintains strong coverage through its Clover Assistant platform and home care offerings.

Amid the significant increase, the company is on course to achieve its first-ever GAAP net income. Cost optimization and positive industry-specific factors are poised to accelerate the path to profitability.

“Together, we believe these dynamics will create compounding earnings and margin expansion over time, which we expect to position Clover to deliver its first year of GAAP net income profitability in 2026,” CEO Andrew Toy remarked.

Clover Health Investments, Corp. (NASDAQ:CLOV) is a healthcare technology company focused on improving medical outcomes for seniors through Medicare Advantage plans and its proprietary software platform, Clover Assistant. It operates as a next-generation insurer providing PPO and HMO plans to Medicare beneficiaries.

Page 3 of 11